Compugen | CGEN - Passivo Circulante





Passivo Circulante Alterar Data
Arca Biopharma USD 16.63M 1.26M 2026-03
aTyr Pharma USD 11.7M 101.49M 2026-03
Bio Path USD 9.15M 468K 2026-03
Brainstorm Cell Therapeutics USD 11.76M 757K 2026-03
Cara Therapeutics USD 11.04M 2K 2025-12
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.04M 533K 2026-03
Immunic USD 38.36M 7.74M 2026-03
Minerva Neurosciences USD 2.29M 381K 2025-12
RedHill Biopharma USD 19.22M 3.07M 2025-12
TherapeuticsMD USD 5.82M 655K 2024-06